Inovio Pharmaceuticals (INO) Change in Accrued Expenses (2009 - 2026)
Inovio Pharmaceuticals (INO) posted Change in Accrued Expenses of $2.39 million for Q2 2026, down 10.4% from $2.66 million a year earlier.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accrued Expenses at Inovio Pharmaceuticals was -$4.4 million; for FY2025, it came in at -$6.42 million.
- In prior years, Inovio Pharmaceuticals' Change in Accrued Expenses was -$3.48 million in FY2024, -$45.99 million in FY2023, $32.61 million in FY2022 (+24.7%) and $26.14 million in FY2021 (+704.0%).
- Quarterly Change in Accrued Expenses has run from a low of -$40.74 million in Q1 2023 to a high of $67.09 million in Q2 2022 over five years.
- According to Business Quant data, Change in Accrued Expenses for the three prior quarters was -$1.86 million (Q1 2026), -$4.58 million (Q4 2025) and -$350,130 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Inovio Pharmaceuticals | 143.02 Mn | -38.21 Mn | - | 1.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.72 Mn |
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | -1.86 Mn |
| Dec 31, 2025 | -4.58 Mn |
| Sep 30, 2025 | -350,130.00 |
| Jun 30, 2025 | 2.66 Mn |
| Mar 31, 2025 | -4.16 Mn |
| Dec 31, 2024 | 864,312.00 |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | 798,193.00 |
| Mar 31, 2024 | -3.16 Mn |
| Dec 31, 2023 | 4.65 Mn |
| Sep 30, 2023 | -6.69 Mn |
| Jun 30, 2023 | -3.22 Mn |
| Mar 31, 2023 | -40.74 Mn |
| Dec 31, 2022 | 5.28 Mn |
| Sep 30, 2022 | -30.77 Mn |
| Jun 30, 2022 | 67.09 Mn |
| Mar 31, 2022 | -9.00 Mn |
| Dec 31, 2021 | 18.87 Mn |
API Access
Inovio Pharmaceuticals Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();